Rapid determination of MICs of 15 antichlamydial agents by using an enzyme immunoassay (Chlamydiazyme)

An enzyme immunoassay (EIA), Chlamydiazyme (Abbott Laboratories), was evaluated for its determination of MICs of 15 antimicrobial agents against Chlamydia trachomatis (MRC-1, LB, TRIC/GB/MRC-1 Gf [ATCC VR-1]). The inoculum size, incubation time, and enhancers were defined for the assessment of chlamydial antigen synthesis in HeLa 229 cells seeded as monolayers in 96-well plates. MICs were determined and defined as the lowest antibiotic concentrations required to inhibit, after 24 or 48 h of incubation, antigen production as determined by the EIA. The MICs (after 48 h) were similar to those determined by the peroxidase-antiperoxidase staining of inclusions. MIC determinations after 24 h were suitable for screening the activities of quinolones, but less so for measuring the susceptibility of C. trachomatis to macrolides and tetracyclines. MIC determination by EIA was rapid, appropriate for standardization, and less cumbersome than determination by quantification of inclusions.

[1]  V. Sambri,et al.  Enzyme-linked immunosorbent assay for the in-vitro detection of sensitivity of Chlamydia trachomatis to antimicrobial drugs. , 1987, The Journal of antimicrobial chemotherapy.

[2]  T. Quinn,et al.  In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis , 1987, Antimicrobial Agents and Chemotherapy.

[3]  W. Black,et al.  In vitro activity of Ro 15-8074, Ro 19-5247, A-56268, and roxithromycin (RU 28965) against Neisseria gonorrhoeae and Chlamydia trachomatis , 1987, Antimicrobial Agents and Chemotherapy.

[4]  G. Ridgway.  A review of the in-vitro activity of roxithromycin against genital pathogens. , 1987, The Journal of antimicrobial chemotherapy.

[5]  G. Ridgway,et al.  The Activity of Ciprofloxacin and Other 4-Quinolones Against Chlamydia trachomatis and Mycoplasmas In Vitro , 1986 .

[6]  V. Sambri,et al.  Comparative in vitro activity of RU 28965 against Chlamydia trachomatis. , 1986, European journal of clinical microbiology.

[7]  C. Hart,et al.  A comparison of the in-vitro activity of antimicrobials against Chlamydia trachomatis examined by Giemsa and a fluorescent antibody stain. , 1985, The Journal of antimicrobial chemotherapy.

[8]  S. Richmond,et al.  Comparison of the in vitro activities of ofloxacin and tetracycline against Chlamydia trachomatis as assessed by indirect immunofluorescence , 1984, Antimicrobial Agents and Chemotherapy.

[9]  M. Hammerschlag.  Activity of trimethoprim-sulfamethoxazole against Chlamydia trachomatis in vitro. , 1982, Reviews of infectious diseases.

[10]  R. Sweet,et al.  Relative resistance to erythromycin in Chlamydia trachomatis , 1980, Antimicrobial Agents and Chemotherapy.

[11]  G. Ridgway,et al.  The antimicrobial susceptibility of Chlamydia trachomatis in cell culture. , 1978, The British journal of venereal diseases.

[12]  W. Bowie,et al.  In vitro assays of the efficacy of antimicrobial agents in controlling Chlamydia trachomatis propagation , 1978, Antimicrobial Agents and Chemotherapy.